 |
 |
 |
 |
 |
 |
 |
 |
Clinical Management
Clinical Management
ICAAC 2006: Index of Coverage
Antiretrovirals in Development
- MK-0518 Demonstrates Potent Efficacy in Patients With Triple-Class-Resistant Virus: 24-Week Results (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - The Integrase Inhibitor MK-0518 Demonstrates a Favorable Lipid Profile (September 27, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
Basic Science
- The Role of the FUT2 Gene in HIV Non-Progression (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
Complications of HIV/HAART
- Comparing the Effects of Rosiglitazone, Pravastatin, Recombinant Human Growth Hormone and Combinations Thereof on HIV-Associated Lipodystrophy (September 30, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Recombinant Human Growth Hormone Produces Pronounced and Durable Reductions in Visceral Adipose Tissue (September 30, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - The Effect of Tenofovir and Other Antiretroviral Therapy on Renal Tubular Cells in Vitro (September 30, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
First-Line Antiretroviral Treatment
- The Once-Daily Abacavir/Lamivudine Co-Formulation Proves Its Mettle by Being Both Safe and Effective (September 30, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Fosamprenavir Efficacy and Safety on Par With Other PIs, With No Gender-Based Differences (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Older People Diagnosed With More Advanced Disease Compared to Younger People (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Risk for AIDS-Defining Events Is Greater Among Antiretroviral-Naive Patients Who Don't Achieve CD4+ Cell Count Above 200 on Treatment (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Zidovudine/Lamivudine/Abacavir May Be Appropriate for Some Treatment-Naive Patients With Low-Baseline Viral Loads (September 28, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
HIV Drug Resistance
- How the HIV-1 Reverse Transcriptase Mutations K65R, M184V and K65R + M184V Produce Resistance to NRTIs (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Phenotypic Clinical Cutoffs for Tipranavir/Ritonavir Defined Based on RESIST Data (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Rise in NRTI Mutations Is Associated With Rise in NNRTI, Protease Inhibitor Mutations (September 28, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
HIV Prevention
- Antiretroviral Drugs as Prevention Tools: PEP, PrEP and Prevention for Positives (September 27, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
Treatment-Experienced Patients
- Tipranavir/Ritonavir-Associated Hepatotoxicity Common, But Resolves Over Time (September 30, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Virologic Outcomes With Tipranavir + Ritonavir Prove to Be Durable Out to 96 Weeks in the RESIST Studies (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Whereas Other PIs Fail, Tipranavir Maintains High-Level Potency Against Key PI Resistance Mutations (September 28, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
Treatment Strategies
- COOL Study: The Ultimate Misnomer? (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Long-Term Lopinavir/Ritonavir Treatment and CD4+ Cell Responses (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - No Difference in HAART Response in Patients With X4-Using HIV (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Reducing the Dose of Lopinavir/Ritonavir Is Associated With Low-Level Viremia (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - An Overview of the Pathogenesis and Treatment of Primary HIV Infection (September 28, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Lower Adherence May Precede Viral Load "Blips" (September 28, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Strategic Use of Antiretroviral Therapy: What to Use and When? (September 28, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
  |
  |